PPD has launched a new site solution for enrolling patients in clinical studies as it proposes enrolling patients first – before activating sites – via a new enrollment model.
Shared manufacturing equipment and utensils used between non-potent and potent drugs were among the cleaning concerns observed by the US FDA in West Virginia, US.
Patient-centric programs for clinical trials, such as travel assistance, are major deciding factors for patients considering participation – and should be standard for all studies, says BBK.
